| scholarly article | Q13442814 |
| P50 | author | Donald F Smee | Q66732853 |
| John D Morrey | Q66760143 | ||
| P2093 | author name string | Justin G Julander | |
| Lawrence M Blatt | |||
| Robert W Sidwell | |||
| Craig W Day | |||
| P2860 | cites work | Clinical characteristics of the West Nile fever outbreak, Israel, 2000 | Q24644796 |
| Pegylated alpha interferon is an effective treatment for virulent venezuelan equine encephalitis virus and has profound effects on the host immune response to infection | Q27469593 | ||
| Interferons, Interferon Inducers, and Interferon-Ribavirin in Treatment of Flavivirus-Induced Encephalitis in Mice | Q27473398 | ||
| Postinfection therapy of arbovirus infections in mice | Q27477850 | ||
| West Nile Virus Infection in the Golden Hamster (Mesocricetus auratus): A Model for West Nile Encephalitis | Q27487802 | ||
| Efficacy of Interferon -2b and Ribavirin Against West Nile Virus In Vitro | Q27489383 | ||
| Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway | Q28216760 | ||
| West Nile virus: a primer for the clinician | Q29620970 | ||
| To interfere and to anti-interfere: the interplay between hepatitis C virus and interferon. | Q30330124 | ||
| Current treatment strategies for chronic hepatitis B and C. | Q31842893 | ||
| Posttherapy suppression of genital herpes simplex virus (HSV) recurrences and enhancement of HSV-specific T-cell memory by imiquimod in guinea pigs | Q33758576 | ||
| Complete genome sequences and phylogenetic analysis of West Nile virus strains isolated from the United States, Europe, and the Middle East | Q34136426 | ||
| Protection Against Japanese Encephalitis Virus in Mice and Hamsters by Treatment with Carboxymethylacridanone, a Potent Interferon Inducer | Q34252046 | ||
| Interferon alfacon-1: a review of its pharmacology and therapeutic efficacy in the treatment of chronic hepatitis C. | Q34385411 | ||
| Combined treatment with interferon-alpha and ribavirin for subacute sclerosing panencephalitis | Q34513371 | ||
| Immunomodulation as a treatment strategy for genital herpes: review of the evidence | Q34606578 | ||
| A review of the applications of imiquimod: a novel immune response modifier | Q34829331 | ||
| Antiherpetic effects of a human alpha interferon analog, IFN-alpha Con1, in hamsters | Q35574141 | ||
| Death from the Nile crosses the Atlantic: the West Nile Fever story | Q35628958 | ||
| Identification of active antiviral compounds against a New York isolate of West Nile virus | Q38884300 | ||
| Interferon inhibits dengue virus infection by preventing translation of viral RNA through a PKR-independent mechanism | Q40593854 | ||
| Antiviral and immunomodulating inhibitors of experimentally-induced Punta Toro virus infections | Q40695542 | ||
| The biologic activity and molecular characterization of a novel synthetic interferon-alpha species, consensus interferon | Q41135955 | ||
| The cooperative effect of interferon-alpha and ribavirin on subacute sclerosing panencephalitis (SSPE) virus infections, in vitro and in vivo | Q42544591 | ||
| Interferon-alpha protects mice against lethal infection with St Louis encephalitis virus delivered by the aerosol and subcutaneous routes | Q42993448 | ||
| Human immunoglobulin as a treatment for West Nile virus infection | Q43047957 | ||
| Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial | Q43049230 | ||
| Significant differences in therapeutic responses to a human interferon-alpha B/D hybrid in Rauscher or Friend murine leukemia virus infections | Q43415389 | ||
| Treatment of recurrent malignant glioma by repeated intracerebral injections of human recombinant interleukin-2 alone or in combination with systemic interferon-alpha. Results of a phase I clinical trial | Q44905240 | ||
| Effect of the combination of interferon-alpha and stavudine on Friend virus infections in (B10.A x A.By)F1 mice | Q45783984 | ||
| P433 | issue | 2 | |
| P921 | main subject | West Nile virus | Q158856 |
| P304 | page(s) | 101-109 | |
| P577 | publication date | 2004-03-01 | |
| P1433 | published in | Antiviral Chemistry & Chemotherapy | Q2853412 |
| P1476 | title | Effect of interferon-alpha and interferon-inducers on West Nile virus in mouse and hamster animal models | |
| P478 | volume | 15 |
| Q30374413 | A TLR3 ligand that exhibits potent inhibition of influenza virus replication and has strong adjuvant activity has the potential for dual applications in an influenza pandemic. |
| Q27490484 | A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo |
| Q37708659 | A review of the epidemiological and clinical aspects of West Nile virus |
| Q28477601 | A thiopurine drug inhibits West Nile virus production in cell culture, but not in mice |
| Q30391956 | Activation of the innate immune system provides broad-spectrum protection against influenza A viruses with pandemic potential in mice |
| Q27472671 | Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival |
| Q37123147 | An inactivated cell culture Japanese encephalitis vaccine (JE-ADVAX) formulated with delta inulin adjuvant provides robust heterologous protection against West Nile encephalitis via cross-protective memory B cells and neutralizing antibody |
| Q27488713 | Antiviral effect of interferon lambda against West Nile virus |
| Q27487859 | Broad-Spectrum Drugs Against Viral Agents |
| Q24646031 | Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection |
| Q37611824 | Clinical manifestations and outcomes of West Nile virus infection |
| Q27478175 | Comparison of the inhibitory effects of interferon alfacon-1 and ribavirin on yellow fever virus infection in a hamster model |
| Q27481326 | Correlation between breakdown of the blood–brain barrier and disease outcome of viral encephalitis in mice |
| Q36322125 | Development of effective therapies against West Nile virus infection |
| Q27485005 | Differential Activation of Human Monocyte-Derived and Plasmacytoid Dendritic Cells by West Nile Virus Generated in Different Host Cells |
| Q27484997 | Differential Effects of Mutations in NS4B on West Nile Virus Replication and Inhibition of Interferon Signaling |
| Q37376398 | Differential virulence and pathogenesis of West Nile viruses |
| Q27481327 | Effect of exogenous interferon and an interferon inducer on western equine encephalitis virus disease in a hamster model |
| Q27487357 | Efficacy of orally administered T-705 pyrazine analog on lethal West Nile virus infection in rodents |
| Q37136479 | Encephalitic Arboviruses: Emergence, Clinical Presentation, and Neuropathogenesis |
| Q30250251 | Epidemiological and clinical aspects on West Nile virus, a globally emerging pathogen. |
| Q28353948 | Equine Immunoglobulin and Equine Neutralizing F(ab')₂ Protect Mice from West Nile Virus Infection |
| Q40063157 | Evaluation of cell viability dyes in antiviral assays with RNA viruses that exhibit different cytopathogenic properties |
| Q27484983 | Identification of Novel Small-Molecule Inhibitors of West Nile Virus Infection |
| Q35382179 | Innate immune control of West Nile virus infection |
| Q27489865 | Innate immune evasion by hepatitis C virus and West Nile virus |
| Q27469771 | Interferon alfacon-1 protects hamsters from lethal pichinde virus infection |
| Q36564942 | Manifestations of West Nile neuroinvasive disease |
| Q36780133 | Mapping and analysis of West Nile virus-specific monoclonal antibodies: prospects for vaccine development |
| Q37726746 | Measure and countermeasure: type I IFN (IFN-alpha/beta) antiviral response against West Nile virus |
| Q40432733 | NIAID resources for developing new therapies for severe viral infections |
| Q40059267 | Neuroinvasive St. Louis Encephalitis Virus Infection in Solid Organ Transplant Recipients |
| Q27009096 | Neurological approaches for investigating West Nile virus disease and its treatment in rodents |
| Q40518678 | Neuromuscular Manifestations of Human West Nile Virus Infection |
| Q40291825 | Neuromuscular manifestations of west nile virus infection |
| Q36124734 | Oligonucleotides and polyribonucleotides: a review of antiviral activity |
| Q27473229 | Poly(I)-Poly(C12U) but Not Ribavirin Prevents Death in a Hamster Model of Nipah Virus Infection |
| Q27489893 | Progress on the development of therapeutics against West Nile virus |
| Q27485635 | Prophylactic and therapeutic intervention of Punta Toro virus (Phlebovirus, Bunyaviridae) infection in hamsters with interferon alfacon-1 |
| Q27480851 | Prophylactic treatment with recombinant Eimeria protein, alone or in combination with an agonist cocktail, protects mice from Banzi virus infection |
| Q34482403 | Protection against West Nile virus infection in mice after inoculation with type I interferon-inducing RNA transcripts. |
| Q60918413 | Rapidly progressive neurologic decline and morbilliform rash presenting in a patient with lymphoma |
| Q33852451 | Small molecule drug discovery for Dengue and West Nile viruses: applying experience from hepatitis C virus |
| Q38772810 | The in vitro and in vivo antiviral properties of combined monoterpene alcohols against West Nile virus infection. |
| Q40480648 | The kinetics of proinflammatory cytokines in murine peritoneal macrophages infected with envelope protein-glycosylated or non-glycosylated West Nile virus. |
| Q33725167 | The therapeutic potential of Toll-like receptor 7 stimulation in asthma |
| Q21245096 | Transcriptomic profile of host response in Japanese encephalitis virus infection |
| Q34933362 | Treatment of yellow fever virus with an adenovirus-vectored interferon, DEF201, in a hamster model |
| Q55379440 | Use of Toll-Like Receptor 3 Agonists Against Respiratory Viral Infections. |
| Q40514804 | Use of interferon-alpha in patients with West Nile encephalitis: report of 2 cases |
| Q40208131 | Variable deficiencies in the interferon response enhance susceptibility to vesicular stomatitis virus oncolytic actions in glioblastoma cells but not in normal human glial cells |
| Q27491033 | Viral pathogenesis in mice is similar for West Nile virus derived from mosquito and mammalian cells |
| Q33718537 | West Nile virus inhibits the signal transduction pathway of alpha interferon |
| Q28260103 | West Nile virus meningoencephalitis |
| Q34567083 | West Nile virus neuroinvasive disease |
| Q51163679 | West nile virus neuroinvasive disease. |
| Q51860606 | West nile virus. |
Search more.